Top 10 Evidence-Based Essentials in Cardiology
-
By
-
April 13, 2026
-
3 min
-
1
ACC/AHA Dyslipidemia Guideline (2026) updates management of dyslipidemias.
-
2
ESC Dyslipidemia Guideline (2025) revises treatment recommendations.
-
3
Heart Failure Guideline (2022) shifts to patient-centered care.
-
4
FOURIER Trial: evolocumab reduces LDL cholesterol risk.
-
5
PREVENT risk equations used for risk assessment in cardiovascular disease.
-
6
CHA₂DS₂-VASc score updates for atrial fibrillation risk.
-
7
Essential data from trials like DAPA-HF and EMPA-REG OUTCOME shape treatment strategies.